Dissatisfaction in Atopic Dermatitis Treatment Revealed; Clear Opportunities for New Entrants
Over four out of 10 physicians and six out of 10 patients are not satisfied with the level of control...
Read MoreSelect Page
Over four out of 10 physicians and six out of 10 patients are not satisfied with the level of control...
Read MoreAn online model for follow-up care of atopic dermatitis that gave patients direct access to dermatologists resulted in equivalent clinical improvement (more…)
Read MoreRegeneron Pharmaceuticals, Inc., and Sanofi today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in (more…)
Read More